2024
- 2024/5/24 – Last week, our CEO Frédéric Pette proudly received a trophy from BPIFrance, marking BioMAdvanced Diagnostics’ selection to join the prestigious Club Excellence.
- 2024/5/1 – Our lab team just got trained on d-PCR technology (Digital PCR).
- 2024/4/25 – We’re thrilled to unveil the commercial name for our project formerly known as “SRDK0921”: BioMAdvanced Kidney SCR Score!
- 2024/4/10 – 1st quarter 2024 – key highlights
- 2024/3/27 – Why can we reach the market faster than most biotech companies and other Medtech ?
- 2024/3/21 – BioMAdvanced Diagnostics Receives Authorization for RNA Export.
- 2024/3/13 – Wondering how we’re able to process our clinical trials at such a rapid pace? The secret lies in Bio-collections (or Biobanks).
- 2024/3/5 – “BioMAdvanced Diagnostics” and its logo have been successfully registered as Trademarks in the United States of America.
- 2024/2/28 – BiomAdvanced Diagnostics is ISO 13485 certified by BSI under certificate number MD 775018.
- 2024/2/21 – Crucial to our product : its ease of use and its safety. How do we ensure it ? By conducting specific usability testing.
- 2024/2/13 – New licence agreement opening a market of 25 million patients worldwide suffering from cancer or kidney failure and at risk for an irreversible muscular atrophy
- 2024/2/6 – BioMAdvanced Diagnostics selected to join the highly selective Bpifrance CLUB EXCELLENCE
- 2024-January Our Yearly Recap : key milestones & achievements
2023
- 2023/12/14 – Bpifrance has just granted us a strategic Seed Investment loan of €250K
- 2023/12/7 – We represented Pays de la Loire at French Tech Rise
- 2023/12/5 – [Lung Product] We have just signed an exclusive unlimited license with the SATT Ouest Valorisation for the patent titled “A blood gene score to prognose chronic lung allograft dysfunction”.
- 2023/11/30 – [Major milestone] Our kidney diagnostic product has successfully completed its first analytical clinical study
- 2023/11/02 – [Editorial] MedTech startups : Who is attractive now? by our CEO, Frédéric PETTE
- 2023/10/05 – We’ve successfully processed the 437 patients tests of our 1st clinical trial for our non-rejection test for patients who have been transplanted with a kidney.
- 2023/09/28 – [IP Policy] Our software is now fully protected. After having successfully passed a 3rd wave of testing it was about time to protect it.
- 2023/09/21 – [Milestone] Our entire supply chain is up and running. This week, we have shipped the 1st batch of our 1st product (the IVD* test of absence of subclinical rejection for patients who received a kidney transplant)
- 2023/09/12 – [Patent] Important news for our development in the US.
- 2023/07/10 – [Financing] BioMAdvanced Diagnostics confirms its growth with a new financing of 1.4 million euros.
- 2023/07/10 – [Communiqué de presse] BioMAdvanced Diagnostics confirme sa croissance avec un nouveau financement de 1,4 million d’euros et lance sa 1ère étude clinique avec le CHU de Nantes
- 2023/07/05 – First clinical study of BioMAdvanced Diagnostics kidney rejection test
- 2023/06/22 – Stage 1 audit for the ISO 13485 certification of our quality system – our notified body concluded with a zero “non compliance”.
- 2023/06/08 – [New Exclusive License] A test for 25 million patients worldwide suffering from cancer or kidney failure and at risk for an irreversible muscular atrophy.
- 2023/05/11/ – Design Freeze for our lung rejection test
- 2023/03/27 – Kidney International publishes ground breaking article authored by our co-founders Sophie Brouard and Richard Danger supporting BMAD’s technology
- 2023/03/24 – Design freeze of our software platform
- 2023/03/09 – Evosciences has agreed to finance most of our laboratory equipment.
- 2023/02/23 – Airbus Développement to support BioMAdvanced Diagnostics
- 2023/02/14 – Eurofins Genomics accepts to deliver to us oligonucleotides under an OEM agreement
2022
- 2023/02/04 – BioMAdvanced Diagnostics has received a €900K grant from BPI France which confirms its “DeepTech” status.
- 2022/09/30 – BioMAdvanced Diagnostics welcomes Mr Steven Roblin as its new Laboratory Technician reporting to Marion cadoux
- 2022/09/27 – BioMAdvanced Diagnostics raises €1,7 million to develop its diagnostics solutions and contribute to improving the life of patients having received a kidney or lung transplant
- 2022/09/14 – BioMAdvanced Diagnostics welcomes Mrs Caroline Legal as its new Regulatory Affairs Engineer, reporting to Madeleine Rambeau
- 2022/09/01 – BioMAdvanced Diagnostics is extremely proud to announce the Design Freeze of its IVD test for Transplant kidney rejection!
- 2022/06/30 – BioMAdvanced Diagnostics enters an agreement with Nantes’ University Hospital to analyze anonymized clinical data from 300 kidney transplant data for its 1st Clinical Performance Study
- 2022/05/11 – On May 11th, 2022 BioMAdvanced Diagnostics has been selected among 200 companies to be one of the 40 French deeptech companies pitching at the Tech Tour France Transfer Invest
- 2022/03/07 – BioMAdvanced Diagnostics announces the appointment and start of its Quality Affairs & Regulatory Affairs Manager
- 2022/02/03 – BioMAdvanced Diagnostics has been granted from SATT Ouest Valorisation an exclusive license for 3 patents relating to the diagnosis of patients who have undergone kidney and/or lung transplantation
- 2022/01/27 – BioMAdvanced Diagnostics announces having received “DeepTech” status from La French Tech and BPI France together with a Bourse French Tech Emergence grant
2021
- 2022/01/12 – BioMAdvanced Diagnostics has launched its Scientific Advisory Board
- 2021/12/03 – BioMAdvanced Diagnostics is one of the 11 companies supported by the Nantes Métropole Fonds Métropolitain d’innovation en santé
- 2021/11/25 – BioMAdvanced selected as a finalist at the Start Innovation CIC Business Awards (edition CIC Ouest)
- 2021/10/29 – BioMadvanced Diagnostics announces IDBC as its selected partner for the design of the Digital part of its developping offering
- 2021/10/19 – BioMAdvanced Diagnostics distinguished and rewarded at Start West 2021
- 2021/10/15 – BioMAdvanced Diagnostics announces its membership to France Biotech
- 2021/10/07 – BioMADvanced Diagnostics announced the support from Réseau Entreprendre Atlantique (REA)
- 2021/10/04 – BioMAdvanced Diagnostics announces the opening of a Quality Manager position
- 2021/10/01 – BioMAdvanced Diagnostics announces the hiring of its 1st Development Engineer
- 2021/09/28 – BioMAdvanced Diagnostics sets up part of its operation at the Faculty of Medicine and at the CRTI in Nantes
- 2021/09/23 – BioMAdvanced Diagnostics is revealed!